On the mechanism of CFTR inhibition by a thiazolidinone derivative

The effects of a thiazolidinone derivative, 3-[(3-trifluoromethyl)phenyl]-5-[(4-carboxyphenyl)methylene]-2-thioxo-4-thiazolidinone (or CFTRinh-172), on cystic fibrosis transmembrane conductance regulator (CFTR) gating were studied in excised inside-out membrane patches from Chinese hamster ovary cells transiently expressing wild-type and mutant CFTR. We found that the application of CFTRinh-172 results in an increase of the mean closed time and a decrease of the mean open time of the channel. A hyperbolic relationship between the closing rate and [CFTRinh-172] suggests that CFTRinh-172 does not act as a simple pore blocker. Interestingly, the potency of inhibition increases as the open time of the channel is increased with an IC50 in the low nanomolar range for CFTR channels locked in an open state for tens of seconds. Our studies also provide evidence that CFTRinh-172 can bind to both the open state and the closed state. However, at least one additional step, presumably reflecting inhibitor-induced conformational changes, is required to shut down the conductance after the binding of the inhibitor to the channel. Using the hydrolysis-deficient mutant E1371S as a tool as the closing rate of this mutant is dramatically decreased, we found that CFTRinh-172–dependent inhibition of CFTR channel gating, in two aspects, mimics the inactivation of voltage-dependent cation channels. First, similar to the recovery from inactivation in voltage-gated channels, once CFTR is inhibited by CFTRinh-172, reopening of the channel can be seen upon removal of the inhibitor in the absence of adenosine triphosphate (ATP). Second, ATP induced a biphasic current response on inhibitor-bound closed channels as if the ATP-opened channels “inactivate” despite a continuous presence of ATP. A simplified six-state kinetic scheme can well describe our data, at least qualitatively. Several possible structural mechanisms for the effects of CFTRinh-172 will be discussed.

[1]  S. S. Smith,et al.  CFTR: mechanism of anion conduction. , 1999, Physiological reviews.

[2]  Douglas C. Rees,et al.  The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism , 2002, Science.

[3]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[4]  D. Sheppard,et al.  Molecular pharmacology of the CFTR Cl- channel. , 1999, Trends in pharmacological sciences.

[5]  K. Barrett,et al.  Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. , 2000, Annual review of physiology.

[6]  Hong Yang,et al.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. , 2002, The Journal of clinical investigation.

[7]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[8]  C. Armstrong,et al.  Ionic pores, gates, and gating currents , 1974, Quarterly Reviews of Biophysics.

[9]  Paola Vergani,et al.  CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains , 2005, Nature.

[10]  Jinglan Zhou,et al.  Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 , 2009, Proceedings of the National Academy of Sciences.

[11]  N. McCarty,et al.  Identification of a region of strong discrimination in the pore of CFTR. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[12]  R. Aldrich,et al.  Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB , 1990, Science.

[13]  P. Grootenhuis,et al.  Pharmacological Rescue of Mutant CFTR Function for the Treatment of Cystic Fibrosis , 2008 .

[14]  K. Locher,et al.  Asymmetry in the Structure of the ABC Transporter-Binding Protein Complex BtuCD-BtuF , 2007, Science.

[15]  F Bezanilla,et al.  Inactivation of the sodium channel. II. Gating current experiments , 1977, The Journal of general physiology.

[16]  Tzyh-Chang Hwang,et al.  CLC-0 and CFTR: chloride channels evolved from transporters. , 2008, Physiological reviews.

[17]  Michael Dean,et al.  Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. , 2005, Annual review of genomics and human genetics.

[18]  G. Nagel,et al.  Dual Effects of Adp and Adenylylimidodiphosphate on Cftr Channel Kinetics Show Binding to Two Different Nucleotide Binding Sites , 1999, The Journal of general physiology.

[19]  A. Taddei,et al.  Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors , 2004, The Journal of general physiology.

[20]  A. Aleksandrov,et al.  Nucleoside triphosphate pentose ring impact on CFTR gating and hydrolysis , 2002, FEBS letters.

[21]  L Csanády,et al.  Rapid kinetic analysis of multichannel records by a simultaneous fit to all dwell-time histograms. , 2000, Biophysical journal.

[22]  K L Magleby,et al.  Estimating kinetic parameters for single channels with simulation. A general method that resolves the missed event problem and accounts for noise. , 1990, Biophysical journal.

[23]  On the Mechanism of MgATP-dependent Gating of CFTR Cl− Channels , 2003, The Journal of general physiology.

[24]  C. Armstrong Interaction of Tetraethylammonium Ion Derivatives with the Potassium Channels of Giant Axons , 1971, The Journal of general physiology.

[25]  T. Hwang,et al.  Probing an Open CFTR Pore with Organic Anion Blockers , 2002, The Journal of general physiology.

[26]  A. Verkman,et al.  CFTR pharmacology and its role in intestinal fluid secretion. , 2003, Current opinion in pharmacology.

[27]  B D Schultz,et al.  Pharmacology of CFTR chloride channel activity. , 1999, Physiological reviews.

[28]  X. Zou,et al.  The Two ATP Binding Sites of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Play Distinct Roles in Gating Kinetics and Energetics , 2006, The Journal of general physiology.

[29]  R. Ravazzolo,et al.  Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis. , 2008, The Biochemical journal.

[30]  J. Ruppersberg,et al.  Cloned neuronal Ik(A) channels reopen during recovery from inactivation , 1991, Nature.

[31]  T. Hwang,et al.  Dual roles of the sixth transmembrane segment of the CFTR chloride channel in gating and permeation , 2010, The Journal of general physiology.

[32]  Y. Sohma,et al.  G551D and G1349D, Two CF-associated Mutations in the Signature Sequences of CFTR, Exhibit Distinct Gating Defects , 2007, The Journal of general physiology.

[33]  Joseph F. Cotten,et al.  Cystic Fibrosis-associated Mutations at Arginine 347 Alter the Pore Architecture of CFTR , 1999, The Journal of Biological Chemistry.

[34]  K. Locher,et al.  Structure of an ABC transporter in complex with its binding protein , 2007, Nature.

[35]  M. Welsh,et al.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.

[36]  X. Zou,et al.  High affinity ATP/ADP analogues as new tools for studying CFTR gating , 2005, The Journal of physiology.

[37]  L. Csanády,et al.  Degenerate ABC composite site is stably glued together by trapped ATP , 2010, The Journal of general physiology.

[38]  T Hoshi,et al.  Biophysical and molecular mechanisms of Shaker potassium channel inactivation , 1990, Science.

[39]  L. Tsui,et al.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.

[40]  D. Rees,et al.  An Inward-Facing Conformation of a Putative Metal-Chelate-Type ABC Transporter , 2007, Science.

[41]  Tsung-Yu Chen,et al.  Blocking Pore-open Mutants of CLC-0 by Amphiphilic Blockers , 2009, The Journal of general physiology.

[42]  R. MacKinnon,et al.  Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors , 2001, Nature.

[43]  A. Taddei,et al.  Altered channel gating mechanism for CFTR inhibition by a high‐affinity thiazolidinone blocker , 2004, FEBS letters.

[44]  A. Taddei,et al.  Differential Sensitivity of the Cystic Fibrosis (CF)-associated Mutants G551D and G1349D to Potentiators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl– Channel* , 2006, Journal of Biological Chemistry.

[45]  K. Locher,et al.  Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNP , 2007, FEBS letters.

[46]  P. Linsdell,et al.  Direct Comparison of the Functional Roles Played by Different Transmembrane Regions in the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Pore* , 2004, Journal of Biological Chemistry.

[47]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[48]  Y. Sohma,et al.  State-dependent modulation of CFTR gating by pyrophosphate , 2009, The Journal of general physiology.

[49]  D. Sheppard,et al.  Gating of the CFTR Cl− channel by ATP‐driven nucleotide‐binding domain dimerisation , 2009, The Journal of physiology.